RSV Diagnostics Market Trends, Size and Insights by Method (Rapid Antigen Detection Tests, Molecular Diagnostic Tests, Others), By End-User (Hospital and Clinics, Clinical Laboratory, Others) – Global Forecast Till 2030

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global RSV Diagnostics Market, by Product

6.1 Introduction

6.2 Kits and Assays

Market Estimates & Forecast, by region, 2020-2027

Market Estimates & Forecast, by country, 2020-2027

6.3 Instruments

Market Estimates & Forecast, by region, 2020-2027

Market Estimates & Forecast, by country, 2020-2027

6.4 Other Products

Market Estimates & Forecast, by region, 2020-2027

Market Estimates & Forecast, by country, 2020-2027

Chapter 7. Global RSV Diagnostics Market, by Method

7.1 Introduction

7.2 Molecular Diagnostics

Market Estimates & Forecast, by region, 2020-2027

Market Estimates & Forecast, by country, 2020-2027

7.3 Rapid Antigen Detection Tests

7.3.1 Enzyme-Linked Immunosorbent Assays

Market Estimates & Forecast, by region, 2020-2027

Market Estimates & Forecast, by country, 2020-2027

7.3.2 Immunofluorescence Assays

Market Estimates & Forecast, by region, 2020-2027

Market Estimates & Forecast, by country, 2020-2027

7.3.3 Other Rapid Antigen Detection Tests

7.3.3.1 Chromatographic Immunoassays

Market Estimates & Forecast, by region, 2020-2027

Market Estimates & Forecast, by country, 2020-2027

7.3.3.2 Optical Immunoassays

Market Estimates & Forecast, by region, 2020-2027

Market Estimates & Forecast, by country, 2020-2027

7.4 Gel Microdroplets

Market Estimates & Forecast, by region, 2020-2027

Market Estimates & Forecast, by country, 2020-2027

7.5 Flow Cytometry

Market Estimates & Forecast, by region, 2020-2027

Market Estimates & Forecast, by country, 2020-2027

7.6 Others

Chapter 8. Global RSV Diagnostics Market, by End-User

8.1 Introduction

8.2 Hospitals and clinics

Market Estimates & Forecast, by region, 2020-2027

Market Estimates & Forecast, by country, 2020-2027

8.3 Clinical Laboratories

Market Estimates & Forecast, by region, 2020-2027

Market Estimates & Forecast, by country, 2020-2027

8.4 Homecare

Market Estimates & Forecast, by region, 2020-2027

Market Estimates & Forecast, by country, 2020-2027

8.5 Others

Chapter 9. Global RSV Diagnostics Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia-Pacific

9.5 The Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Quest Diagnostics

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Biomerieux

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Becton, Dickinson and Company (BD)

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Abbott

11.4.1 Company Overview

11.4.2 Technology/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 F.Hoffman-La Roche Ltd.

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Danaher Corporation

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Thermo Fisher Scientific

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Biocartis

11.8.1 Overview

11.8.2 Product/ Technology Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Luminex

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Hologic

11.10.1 Overview

11.10.2 Product Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Fast Track Diagnostics

11.11.1 Overview

11.11.2 Product Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 Bio-Rad Laboratories Inc.

11.12.1 Overview

11.12.2 Product Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.13 Alere Inc.

11.13.1 Overview

11.13.2 Product Overview

11.13.3 Financials

11.13.4 Key Developments

11.13.5 SWOT Analysis

11.14 Quidel Corporation

11.14.1 Overview

11.14.2 Product Overview

11.14.3 Financials

11.14.4 Key Developments

11.14.5 SWOT Analysis

11.15 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of the RSV diagnostics Instruments Industry

Chapter 13 Appendix

LIST OF TABLES

Table 1 Global RSV Diagnostics Market Synopsis, 2020-2027

Table 2 Global RSV Diagnostics Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Global RSV Diagnostics Market, by Region, 2020-2027, (USD Million)

Table 4 Global RSV Diagnostics Market, by Product, 2020-2027, (USD Million)

Table 5 Global RSV Diagnostics Market, by Method, 2020-2027, (USD Million)

Table 6 Global RSV Diagnostics Market, by End-User, 2020-2027, (USD Million)

Table 7 North America Global RSV Diagnostics Market, by Product, 2020-2027, (USD Million)

Table 8 North America Global RSV Diagnostics Market, by Method, 2020-2027, (USD Million)

Table 9 North America Global RSV Diagnostics Market, by End-User, 2020-2027, (USD Million)

Table 10 US RSV Diagnostics Market, by Product, 2020-2027, (USD Million)

Table 11 US RSV Diagnostics Market, by Method, 2020-2027, (USD Million)

Table 12 US RSV Diagnostics Market, by End-User, 2020-2027, (USD Million)

Table 13 Canada RSV Diagnostics Market, by Product, 2020-2027, (USD Million)

Table 14 Canada RSV Diagnostics Market, by Method, 2020-2027, (USD Million)

Table 15 Canada RSV Diagnostics Market, by End-User, 2020-2027, (USD Million)

Table 16 South America RSV Diagnostics Market, by Product, 2020-2027, (USD Million)

Table 17 South America RSV Diagnostics Market, by Method, 2020-2027, (USD Million)

Table 18 South America RSV Diagnostics Market, by End-User, 2020-2027, (USD Million)

Table 19 Europe RSV Diagnostics Market, by Product, 2020-2027, (USD Million)

Table 20 Europe RSV Diagnostics Market, by Method, 2020-2027, (USD Million)

Table 21 Europe RSV Diagnostics Market, by End-User, 2020-2027, (USD Million)

Table 22 Western Europe RSV Diagnostics Market, by Product, 2020-2027, (USD Million)

Table 23 Western Europe RSV Diagnostics Market, by Method, 2020-2027, (USD Million)

Table 24 Western Europe RSV Diagnostics Market, by End-User, 2020-2027, (USD Million)

Table 25 Eastern Europe RSV Diagnostics Market, by Product, 2020-2027, (USD Million)

Table 26 Eastern Europe RSV Diagnostics Market, by Method, 2020-2027, (USD Million)

Table 27 Eastern Europe RSV Diagnostics Market, by End-User, 2020-2027, (USD Million)

Table 28 Asia-Pacific RSV Diagnostics Market, by Product, 2020-2027, (USD Million)

Table 29 Asia-Pacific RSV Diagnostics Market, by Method, 2020-2027, (USD Million)

Table 30 Asia-Pacific RSV Diagnostics Market, by End-User, 2020-2027, (USD Million)

Table 31 Middle East & Africa RSV Diagnostics Market, by Product, 2020-2027, (USD Million)

Table 32 Middle East & Africa RSV Diagnostics Market, by Method, 2020-2027, (USD Million)

Table 33 Middle East & Africa RSV Diagnostics Market, by End-User, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global RSV Diagnostics Market

Figure 3 Segmentation Market Dynamics for Global RSV Diagnostics Market

Figure 4 Global RSV Diagnostics Market Share, by Product, 2020

Figure 5 Global RSV Diagnostics Market Share, by Method, 2020

Figure 6 Global RSV Diagnostics Market Share, by End-User, 2020

Figure 7 Global RSV Diagnostics Market Share, by Region, 2020

Figure 8 North America RSV Diagnostics Market Share, by Country, 2020

Figure 9 Europe RSV Diagnostics Market Share, by Country, 2020

Figure 10 Asia-Pacific RSV Diagnostics Market Share, by Country, 2020

Figure 11 Middle East & Africa RSV Diagnostics Market Share, by Country, 2020

Figure 12 Global RSV Diagnostics Market: Company Share Analysis, 2020 (%)

Figure 13 Quest Diagnostics: Key Financials

Figure 14 Quest Diagnostics: Segmental Revenue

Figure 15 Quest Diagnostics: Geographical Revenue

Figure 16 Biomerieux: Key Financials

Figure 17 Biomerieux: Segmental Revenue

Figure 18 Biomerieux: Geographical Revenue

Figure 19 Becton, Dickinson and Company (BD):: Key Financials

Figure 20 Becton, Dickinson and Company (BD): Segmental Revenue

Figure 21 Becton, Dickinson and Company (BD): Geographical Revenue

Figure 22 Abbott: Key Financials

Figure 23 Abbott: Segmental Revenue

Figure 24 Abbott: Geographical Revenue

Figure 25 F.Hoffman-La Roche Ltd.: Key Financials

Figure 26 F.Hoffman-La Roche Ltd.: Segmental Revenue

Figure 27 F.Hoffman-La Roche Ltd. Geographical Revenue

Figure 28 Danaher Corporation: Key Financials

Figure 29 Danaher Corporation: Segmental Revenue

Figure 30 Danaher Corporation: Geographical Revenue

Figure 31 Thermo Fischer Scientific: Key Financials

Figure 32 Thermo Fischer Scientific: Segmental Revenue

Figure 33 Thermo Fischer Scientific: Geographical Revenue

Figure 34 Biocartis: Key Financials

Figure 35 Biocartis: Segmental Revenue

Figure 36 Biocartis: Geographical Revenue

Figure 37 Luminex: Key Financials

Figure 38 Luminex: Segmental Revenue

Figure 39 Luminex: Geographical Revenue

Figure 40 Hologic: Key Financials

Figure 41 Hologic: Segmental Revenue

Figure 42 Hologic: Geographical Revenue

Figure 43 Fast Track Diagnostics: Key Financials

Figure 44 Fast Track Diagnostics Segmental Revenue

Figure 45 Fast Track Diagnostics: Geographical Revenue

Figure 46 Bio-Rad Laboratories Inc.: Key Financials

Figure 47 Bio-Rad Laboratories Inc.: Segmental Revenue

Figure 48 Bio-Rad Laboratories Inc.: Geographical Revenue

Figure 49 Alere, Inc.: Key Financials

Figure 50 Alere, Inc.: Segmental Revenue

Figure 51 Alere, Inc: Geographical Revenue

Figure 52 Quidel Corporation: Key Financials

Figure 53 Quidel Corporation: Segmental Revenue

Figure 54 Quidel Corporation: Geographical Revenue